CBA FY23 results: As good as it’ll get for any of the banks this reporting season

Nick Sundich Nick Sundich, August 9, 2023

Investors are spending this morning glossing over the eagerly anticipated CBA FY23 results. Overall, it appears there’s more good than bad and investors seemingly agree. But the outlook is far from certain.




The headline CBA FY23 results look good

CBA recorded a $10.2bn NPAT, a figure up 5% from FY22. The company said this was ‘supported by growth in net interest income, partly offset by higher loan impairment expenses and operating costs’. In other words, it is making more money from home loan interest, but not as much as it would if it weren’t for higher operating costs and bad debts.

The company’s NIM was 2.07%, up 17 basis points from FY22. Shareholders may have expected further growth, but the mortgage wars are taking their toll on all the banks’ margins and CBA reiterated that margins peaked in late CY22.

Home lending grew at the rate of the system, growing by 5% to $26.2bn. Household deposits only grew by 0.7x the system, by 5.2% to $18.3bn. But Business lending rose by 1.4x the system, by 11.4% to $14.5bn.

CBA’s CET1 ratio was 12.2%, up 10 basis points in 6 months. It recorded a 14% Return on Equity (RoE) and it will be paying a $4.50 per share dividend – a yield of just over 4%.

It boasted that its returns to investors (through dividends and share buybacks) would benefit over 12m Australians, both direct shareholders and indirect holders through superannuation funds that hold the bank’s shares. Does it make up for only gaining 3% in the last year and only 2% today? Well, it depends on whether or not investors wanted dividends, what portion of their investment portfolio was made up of CBA shares and what other investments were held.


CBA (ASX:CBA) share price chart, log scale (Source: TradingView)


The outlook is uncertain, but CBA is better placed

The mortgage wars are far from over. But, as we noted before, we think CBA is better equipped than its peers for several reasons including its market position, early ditching of its cashback offer and lower deposit interest rates than its peers.

CEO Matt Comyn told shareholders the company was well provisioned for the changing financial conditions, with a strong balance sheet.


Stocks Down Under Concierge is here to help you pick winning stocks!

The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector!

Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.

Our performance is well ahead of the ASX200 and All Ords.

You can try out Concierge … for FREE.




There’s no credit card needed – the trial expires automatically.



Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

best stocks

5 Best Stocks Under $100 To Buy Now

If you’re new to investing and don’t have a lot of money to start with, will you be missing out…

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): Is there further upside to be excited for in FY25?

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

like for like sales

Like for like sales: What does it mean and why do retailers use that creative term?

ASX retailers often use ‘like for like’ sales in addition to total sales. It is most common for companies that…